Published in Am J Epidemiol on May 01, 1971
Vestibular reactions associated with minocycline. Antimicrob Agents Chemother (1975) 1.04
Side effects of minocycline: a double-blind study. Antimicrob Agents Chemother (1977) 1.03
Entry of four tetracyclines into saliva and tears. Antimicrob Agents Chemother (1974) 0.85
Prophylactic use of antibiotics for prevention of meningococcal infections: systematic review and meta-analysis of randomised trials. Eur J Clin Microbiol Infect Dis (2005) 0.80
Infections diseases: meningococcal disease. West J Med (2000) 0.79
Comparison of susceptibility of Neisseria meningitidis to sodium sulphadiazine and sodium fusidate in vitro. J Clin Pathol (1978) 0.78
The effect of minocycline on potassium leakage from red cells: a study of the genetics and relationship to vestibular adverse reactions. J Med Genet (1982) 0.76
Editorial: Meningococcal infections. Br Med J (1974) 0.75
Parvovirus genome: nucleotide sequence of H-1 and mapping of its genes by hybrid-arrested translation. J Virol (1983) 3.00
Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci (1971) 2.95
trans-Activation of parvovirus P38 promoter by the 76K noncapsid protein. J Virol (1985) 2.83
Diagnosis of bacterial meningitis by counterimmunoelectrophoresis. J Lab Clin Med (1972) 2.57
Characterization of the trans-activation-responsive element of the parvovirus H-1 P38 promoter. J Virol (1987) 2.25
Replication process of the parvovirus H-1. I. Kinetics in a parasynchronous cell system. J Virol (1973) 2.24
The usefulness of screening for mental illness. Lancet (1984) 2.12
Identification of Neisseria meningitidis carbohydrate fermentation patterns in Mueller-Hinton broth. J Bacteriol (1968) 2.03
DNA sequence of the 5' terminus containing the replication origin of parvovirus replicative form DNA. J Virol (1982) 2.01
Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis (1977) 1.92
Replication process of the parvovirus H-1 V. Isolation and characterization of temperature-sensitive H-1 mutants. J Virol (1976) 1.90
Proposed model for screening antimicrobial agents for potential use in eliminating meningococci from the nasopharynx of healthy carriers. Antimicrob Agents Chemother (Bethesda) (1968) 1.82
Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci. J Infect Dis (1966) 1.82
Relationship of Serogroups of Neisseria meningitidis I. Microagglutination, Gel Diffusion, and Slide Agglutination Studies of Meningococcal Antisera Before and After Absorption with RAS-10 Strain of Meningococci. Infect Immun (1970) 1.79
The NCHS pilot project to link birth and infant death records: stage 1. Public Health Rep (1987) 1.76
Rifampin: effect of two-day treatment on the meningococcal carrier state and the relationship to the levels of drug in sera and saliva. Am J Med Sci (1971) 1.74
Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state. JAMA (1970) 1.72
Nucleotide sequence of the coat protein gene of canine parvovirus. J Virol (1985) 1.71
Replication process of the parvovirus H-1. IV. H-1-specific proteins synthesized in synchronized human NB kidney cells. J Virol (1974) 1.66
Replication process of the parvovirus H-1. VI. Characterization of a replication terminus of H-1 replicative-form DNA. J Virol (1977) 1.65
Construction of a genetic switch for inducible trans-activation of gene expression in eucaryotic cells. J Virol (1987) 1.65
Replication process of the parvovirus H-1. II. Isolation and characterization of H-1 replicative form DNA. J Virol (1974) 1.64
The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. J Infect Dis (1971) 1.63
Replication process of the parvovirus H-1. III. Factors affecting H-1 RF DNA synthesis. J Virol (1974) 1.57
Replication process of the parvovirus H-1. VII. Electron microscopy of replicative-form DNA synthesis. J Virol (1977) 1.53
Replication process of the parvovirus H-1. X. Isolation of a mutant defective in replicative-form DNA replication. J Virol (1978) 1.50
Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its functions for viral DNA replication, late promoter trans activation, and cytotoxicity. J Virol (1990) 1.45
Defective interfering particles of parvovirus H-1. J Virol (1978) 1.44
Percutaneous release of the trigger finger: an office procedure. J Hand Surg Am (1992) 1.44
Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, California. Am J Epidemiol (1970) 1.34
Religion and fertility in the United States: new patterns. Demography (1992) 1.33
Phylogenetic and physical analysis of the 5' leader RNA sequences of avian retroviruses. Nucleic Acids Res (1991) 1.31
Complementation for replicative form DNA replication of a deletion mutant of H-1 by various parvoviruses. J Virol (1982) 1.31
Canine parvovirus: a biochemical and ultrastructural characterization. J Gen Virol (1982) 1.27
The use of guanidine thiocyanate to fractionate DNA-like RNA adsorbed on methylated bovine albumin-kieselguhr columns. Biochim Biophys Acta (1969) 1.26
Replication process of the parvovirus H-1. IX. Physical mapping studies of the H-1 genome. J Virol (1977) 1.21
Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cells in vivo and in vitro. Virology (1991) 1.20
Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells. J Virol (1995) 1.15
Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors in Syrian hamsters by prior infection with H-1 parvovirus. Cancer Res (1982) 1.14
Parvovirus NS1 stimulates P4 expression by interaction with the terminal repeats and through DNA amplification. J Virol (1991) 1.13
Replication process of the parvovirus H-1. VIII. Partial denaturation mapping and localization of the replication origin of H-1 replicative-form DNA with electron microscopy. J Virol (1977) 1.10
Epidemiology of the common cold in military recruits with emphasis on infections by rhinovirus types 1A, 2, and two unclassified rhinoviruses. Am J Epidemiol (1971) 1.09
Parvovirus H-1 P38 promoter requires the trans-activation region (tar), an SP1 site, and a TATA box for full activity. Virology (1992) 1.07
The outcome of infected arthroplasty of the knee. J Bone Joint Surg Br (1986) 1.06
Spectra of susceptibility of Neisseria meningitidis to antimicrobial agents in vitro. Appl Microbiol (1970) 1.06
Ultrastructural studies of H-1 parvovirus replication. IV. Crystal development and structure with the temperature-sensitive mutant ts1. J Virol (1977) 1.06
A controlled multicenter trial of 2,3-dihydro-1-H-pyridino (2,3-b)(1,4)-thiazine-2-one in rheumatoid arthritis. J Clin Pharmacol (1973) 1.05
Mimosine inhibits viral DNA synthesis through ribonucleotide reductase. Virology (1994) 1.02
A longitudinal study of Mycoplasma pneumoniae: infections in Navy recruits by isolation and seroepidemiology. Am J Epidemiol (1976) 1.01
Ultrastructural studies of H-1 parvovirus replication. V. Immunocytochemical demonstration of separate chromatin-associated and inclusion-associated antigens. J Virol (1977) 0.99
Electron microscope methods for the identification of adenoviruses isolated in micro tissue cultures. Appl Microbiol (1972) 0.99
Control of nucleic acid synthesis in human diploid cells undergoing contact inhibition. Exp Cell Res (1968) 0.99
The anatomy of the patellar tendon. Knee Surg Sports Traumatol Arthrosc (2001) 0.98
Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers. Mil Med (1973) 0.97
Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia. AJNR Am J Neuroradiol (2009) 0.96
Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. Am J Epidemiol (1973) 0.96
Differences between sexes in the nasopharyngeal carriage of Neisseria meningitidis. Am J Epidemiol (1977) 0.95
Religion and fertility in the United States: the importance of marriage patterns and Hispanic origin. Demography (1986) 0.95
Ultrasonic characterization of human cancellous bone in vitro using three different apparent backscatter parameters in the frequency range 0.6-15.0 mhz. IEEE Trans Ultrason Ferroelectr Freq Control (2008) 0.93
Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Hum Gene Ther (1993) 0.89
Early diagnosis of atlanto-axial rotatory fixation. J Bone Joint Surg Br (1986) 0.88
Effects of formaldehyde on the mucous membranes and lungs. A study of an industrial population. JAMA (1988) 0.88
Anterior midline or medial parapatellar incision for arthroplasty of the knee. A comparative study. J Bone Joint Surg Br (1986) 0.88
The timing of tourniquet application in relation to prophylactic antibiotic administration. J Bone Joint Surg Br (1988) 0.87
The value of MR imaging in the diagnosis of the os trigonum syndrome. Skeletal Radiol (1996) 0.87
Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice. J Gen Virol (1993) 0.86
The parvovirus H-1 NS2 protein affects viral gene expression through sequences in the 3' untranslated region. Virology (1993) 0.86
Conservation of the 17-kilodalton antigen gene within the genus Bartonella. Clin Diagn Lab Immunol (2000) 0.85
Relationship of serogroups of Neisseria meningitidis. II. R variants of Neisseria meningitidis. Infect Immun (1972) 0.85
Extracting the pertinent from the irrelevant. Minn Med (1994) 0.85
Elbow hemiarthroplasty with 20-year follow-up study. A case report and literature review. Clin Orthop Relat Res (1990) 0.84
Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits. Antimicrob Agents Chemother (Bethesda) (1965) 0.83